CM Spier
Impact in
-
- Lymphoma Diagnosis and Treatment
- Hematology top 5%
- Multiple Myeloma Research and Treatments
- Acute Myeloid Leukemia Research
Papers in
-
- Lymphoma Diagnosis and Treatment 4
-
- Multiple Myeloma Research and Treatments 2
- Co-authors
- TM Grogan (9 shared papers)TP Miller (4 shared papers)Monika B. Matzner (2 shared papers)Lippman Sm (2 shared papers)Donald J. Slymen (2 shared papers)L Richter (4 shared papers)James A. Rybski (2 shared papers)Carl R. Kjeldsberg (2 shared papers)
- Journals
- Blood (7 papers)PubMed (4 papers)
- Partner nations
- United States
In The Last Decade
CM Spier
11 papers receiving 1.0k citations
Peers
Comparison fields: 5 of 32
- Pathology and Forensic Medicine 454
- Hematology 178
- Oncology 130
- Dermatology 24
- Genetics 22
Countries citing papers authored by CM Spier
This map shows the geographic impact of CM Spier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by CM Spier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites CM Spier more than expected).
Fields of papers citing papers by CM Spier
This network shows the impact of papers produced by CM Spier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by CM Spier. The network helps show where CM Spier may publish in the future.
Co-authors
The 20 scholars most cited alongside CM Spier, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1994 | 221 | |
| 2 | 1992 | 201 | |
| 3 | 1988 | 200 | |
| 4 | 1993 | 183 | |
| 5 | 1988 | 123 | |
| 6 | 1989 | 89 | |
| 7 | T-cell antigen-positive multiple myeloma. | 1990 | 21 |
| 8 | Nuclear contour irregularity correlates with Leu-9-, Leu-8- cells in benign lymphoid infiltrates of skin. An ultrastructural morphometric and quantitative immunophenotypic analysis suggesting the normal T-cell counterpart to the malignant mycosis fungoides/Sézary cell. | 1988 | 14 |
| 9 | 1984 | 11 | |
| 10 | Differentiation of chronic lymphocytic leukemia from other "well to intermediate differentiated" lymphoproliferative disorders by the mouse rosette assay. | 1986 | 6 |
| 11 | Isolated ocular involvement in non-Hodgkin's lymphoma with immunocytochemical evaluation. | 1993 | 1 |
About CM Spier
CM Spier is a scholar working on Pathology and Forensic Medicine, Hematology, Dermatology, Genetics and Neurology, having authored 11 papers that have together received 1.1k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (4 papers), Multiple Myeloma Research and Treatments (2 papers), CNS Lymphoma Diagnosis and Treatment (1 paper), Chronic Lymphocytic Leukemia Research (1 paper), Drug Transport and Resistance Mechanisms (1 paper), Cutaneous lymphoproliferative disorders research (1 paper) and Acute Lymphoblastic Leukemia research (1 paper). The work is most often cited by research in Pathology and Forensic Medicine (454 citations), Hematology (178 citations), Oncology (130 citations), Dermatology (24 citations) and Genetics (22 citations). CM Spier has collaborated with scholars based in United States. Frequent co-authors include TM Grogan, TP Miller, Monika B. Matzner, Lippman Sm, Donald J. Slymen, L Richter, James A. Rybski, Carl R. Kjeldsberg, Rik J. Scheper and William S. Dalton. Their work appears in journals such as Blood and PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.